Cystic Fibrosis is an example of a genetic disease which so profound, screens to determine if one or both parents are carriers have been available for many years. NxGen MDX has devised a panel of 113 + serious, clinically actionable, and prevalent conditions which make up their Super Panel. Eighty per cent (80%) of children born with genetic disease have no family history of the condition. Traditionally, carrier screening based on their ethnic background or family history, but this approach missed a great number of affected children. We have partnered with NxGen MDX to offer Super Panel to any of our patients who are interested in preventing passing inherited disorders to their children. For severely debilitating diseases, you would have the ability to identify which of your embryos had the disease through a process called Preimplantation Genetic Diagnosis (PGD), and prevent passing this inherited disorder to your children.
If one partner were affected, you have the option to screen the other partner, and know the probability of having a child with that condition. This process is called “carrier screening” and it allows us to screen one partner for any number of genetic mutations which if passed on to their offspring would lead to a known disease. This technology allows us to actually prevent diseases for which we have no cure. The Human Genome Project first sequenced the Human Genome in 2003, which lead to several breakthroughs in genetic screening which are seemingly miraculous.
0 kommentar(er)
